Navigation Links
Localized reactive badger culling raises bovine tuberculosis risk, new analysis confirms
Date:7/13/2011

Localised badger culling in response to bovine tuberculosis (TB) outbreaks increases the risk of infection in nearby herds, according to a new analysis.

The study, by researchers at the Medical Research Council Centre for Outbreak Analysis and Modelling at Imperial College London, is published today in the Royal Society journal Biology Letters.

The findings come as the Government prepares to decide whether to license farmers to organise the widespread culling of badgers over areas of 150 square kilometres or more in western England.

Bovine TB is a major animal health problem in Britain. In 2009, one in every 10 cattle herds tested showed evidence of bovine TB, leading to 35,000 cattle being slaughtered. In the last decade, the slaughter of infected cattle has cost around 500 million to the taxpayer.

Efforts to control the disease have been hampered by the persistence of Mycobacterium bovis, the bacterium that causes bovine TB, in the wild badger population, and transmission of the disease between species.

The new analysis found that the presence of any reactive culling activity in the previous year within one kilometre of a herd more than doubled the risk of bovine TB, even after adjusting for the number of confirmed outbreaks nearby. The number of badgers culled in the vicinity of the herd was also associated with increased bovine TB risk.

"These findings add to the evidence that localised reactive badger culling has a detrimental effect on tuberculosis risk for cattle," said Professor Christl Donnelly, from the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, who led the study. "This may explain why culls in the past were ineffective at reducing the incidence of bovine TB."

The findings may be linked to the observation that surviving badgers in a partly-culled group wander over a larger area, increasing their contact with neighbouring cattle. This is known as the 'perturbation effect'.

The analysis was based on data from the Randomised Badger Culling Trial (RBCT), set up in 1998 by the Department for Environment, Food and Rural Affairs (Defra) to evaluate the impact of badger culling on bovine TB risk in cattle. In the RBCT, trial areas were randomly assigned to three strategies: repeated proactive culling across the whole area; reactive one-off localised culling on and around farms following outbreaks, and no culling.

The first analysis of trial data, published in 2003, found that localised badger culling increased the incidence of bovine TB in cattle, leading to reactive culling being suspended. However, some researchers questioned the way in which the results were interpreted.

The new analysis, using data from 1998 to 2007, considered only herds in the reactive culling areas. The researchers carried out a 'case-control analysis' of 604 pairs of herds, comparing herds with confirmed bovine TB outbreaks with herds that were tested but revealed no evidence of infection.


'/>"/>

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London
Source:Eurekalert

Related medicine news :

1. Researchers examine procedure utilization trends in patients with clinically localized renal masses
2. NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer
3. Kidney removal does not prolong the lives of elderly patients with localized kidney cancer
4. LocalPrinting.com Announces Launch of Customized, Localized Print Website MiamiBusinessCards.com
5. Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds
6. Over-reactive immune system kills young adults during pandemic flu
7. C-Reactive Protein Levels Vary By Race: Study
8. Antibiotic regimen effective for reactive arthritis
9. Too Much TV Raises Risk of Diabetes, Heart Disease and Death
10. Good Sleep Raises Quality of Life, Lowers Depression
11. Obesity raises breast cancer survivors risk of dying of the cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
Breaking Medicine Technology: